Literature DB >> 16511380

Hospitalization for respiratory syncytial virus infection in young children: development of a clinical prediction rule.

Edwin Rietveld1, Yvonne Vergouwe, Ewout W Steyerberg, Marianne W A Huysman, Ronald de Groot, Henriëtte A Moll.   

Abstract

BACKGROUND: Because passive immunization against respiratory syncytial virus (RSV) is costly, its use should be restricted to well-defined groups of high risk children. We aimed to develop a clinical prediction rule that estimates the individual monthly risk of hospitalization for RSV infection in young children.
METHODS: A retrospective cohort study was conducted in the southwestern part of The Netherlands. We included children born between January 1, 1996 and December 31, 1998. Children hospitalized for proven RSV infection were compared with children not hospitalized for RSV infection. The monthly risk was estimated with a logistic regression model including 5 clinical predictors (gender, gestational age, birth weight, presence of bronchopulmonary dysplasia and age) and the mean seasonal monthly pattern of RSV infections. We compared the predictive performance of the prediction rule with the guidelines of the American Academy of Pediatrics (AAP).
FINDINGS: Information was collected on 2469 hospitalized children and 140,661 children who were 1,181,790 months at risk. All predictors were statistically significant, with age and the seasonal monthly RSV pattern having the strongest effects. The clinical prediction rule that included these predictors could better discriminate between high and low risk children than the AAP guidelines and would potentially reduce the number of immunizations by 20%.
INTERPRETATION: The prediction rule reliably estimates individual monthly risks of hospitalization for RSV infection in the population studied. It provides an improved index for passive immunization but further validation in other populations is required.

Entities:  

Mesh:

Year:  2006        PMID: 16511380     DOI: 10.1097/01.inf.0000202135.24485.f8

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  17 in total

1.  Preventing hospitalizations for respiratory syncytial virus infection.

Authors:  Joan L Robinson; Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

2.  RSV infection among children born moderately preterm in a community-based cohort.

Authors:  Rolof G P Gijtenbeek; Jorien M Kerstjens; Sijmen A Reijneveld; Eric J Duiverman; Arend F Bos; Elianne J L E Vrijlandt
Journal:  Eur J Pediatr       Date:  2014-09-06       Impact factor: 3.183

3.  Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.

Authors:  Hajrija Maksić; Suada Heljić; Fahrija Skokić; Darinka Šumanović-Glamuzina; Veroslava Milošević; Almir Zlatanović; Notario Gerard
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

4.  Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Michelle D Stevenson; Ashley F Sullivan; Tate F Forgey; Sunday Clark; Janice A Espinola; Carlos A Camargo
Journal:  Pediatrics       Date:  2012-08-06       Impact factor: 7.124

Review 5.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

6.  Health-related quality of life in preschool children in five health conditions.

Authors:  A T Spuijbroek; R Oostenbrink; J M Landgraf; E Rietveld; A de Goede-Bolder; E F van Beeck; M van Baar; H Raat; H A Moll
Journal:  Qual Life Res       Date:  2010-12-12       Impact factor: 4.147

Review 7.  Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.

Authors:  Ting Shi; Evelyn Balsells; Elizabeth Wastnedge; Rosalyn Singleton; Zeba A Rasmussen; Heather J Zar; Barbara A Rath; Shabir A Madhi; Stuart Campbell; Linda Cheyenne Vaccari; Lisa R Bulkow; Elizabeth D Thomas; Whitney Barnett; Christian Hoppe; Harry Campbell; Harish Nair
Journal:  J Glob Health       Date:  2015-12       Impact factor: 4.413

8.  A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom.

Authors:  Anthony Bentley; Ivana Filipovic; Katherine Gooch; Katharina Büsch
Journal:  Health Econ Rev       Date:  2013-08-06

9.  A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study.

Authors:  Eric A F Simões; Xavier Carbonell-Estrany; John R Fullarton; Johannes G Liese; Jose Figueras-Aloy; Gunther Doering; Juana Guzman
Journal:  Respir Res       Date:  2008-12-08

10.  Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.

Authors:  Koen B Pouwels; Sefika E Bozdemir; Selen Yegenoglu; Solmaz Celebi; E David McIntosh; Serhat Unal; Maarten J Postma; Mustafa Hacimustafaoglu
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.